<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e645a-c2f6-7df8-bb13-aa40b3230fec,g:d36d5b7f-4a73-4138-af5a-19bc17fe2702-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://mirumpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="mirm-20260630.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e645a-c47f-7e6b-b9e6-16f61ade6389" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_019e645a-c47f-7d07-9ef6-68203678911a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e645a-c47f-7e6b-b9e6-16f61ade6389" xlink:to="loc_us-gaap_ShortTermInvestments_019e645a-c47f-7d07-9ef6-68203678911a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019e645a-c47f-76ff-a0bd-db4bc02a34db" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e645a-c47f-7e6b-b9e6-16f61ade6389" xlink:to="loc_us-gaap_InventoryNet_019e645a-c47f-76ff-a0bd-db4bc02a34db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e645a-c47f-76b6-b6ec-b7481e9d76a2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e645a-c47f-7e6b-b9e6-16f61ade6389" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e645a-c47f-76b6-b6ec-b7481e9d76a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019e645a-c47f-7004-8c6a-5f512b03577c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e645a-c47f-7e6b-b9e6-16f61ade6389" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019e645a-c47f-7004-8c6a-5f512b03577c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e645a-c47f-7bb6-9e29-7a2802c9c614" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e645a-c47f-7e6b-b9e6-16f61ade6389" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e645a-c47f-7bb6-9e29-7a2802c9c614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e645a-c47f-7f49-8c2c-77691b6dc6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e645a-c47f-739a-a2f5-aecaafa357af" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e645a-c47f-7f49-8c2c-77691b6dc6e1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e645a-c47f-739a-a2f5-aecaafa357af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e645a-c47f-7918-a704-989fa49fbcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e645a-c47f-7f49-8c2c-77691b6dc6e1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e645a-c47f-7918-a704-989fa49fbcb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e645a-c47f-7758-be13-e80f803d4964" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e645a-c47f-7f49-8c2c-77691b6dc6e1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e645a-c47f-7758-be13-e80f803d4964" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e645a-c47f-7957-b3f3-c3fbbe32bff6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e645a-c47f-7f49-8c2c-77691b6dc6e1" xlink:to="loc_us-gaap_PreferredStockValue_019e645a-c47f-7957-b3f3-c3fbbe32bff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e645a-c47f-77a6-919b-fa1e3065678c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e645a-c47f-7f49-8c2c-77691b6dc6e1" xlink:to="loc_us-gaap_CommonStockValue_019e645a-c47f-77a6-919b-fa1e3065678c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e645a-c47f-750b-aae1-f2f58c6e08ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019e645a-c47f-741e-9423-2adf1a9f5e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e645a-c47f-750b-aae1-f2f58c6e08ff" xlink:to="loc_us-gaap_AccountsPayableCurrent_019e645a-c47f-741e-9423-2adf1a9f5e8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_019e645a-c47f-7cd7-b80a-dcb902f35d20" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e645a-c47f-750b-aae1-f2f58c6e08ff" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_019e645a-c47f-7cd7-b80a-dcb902f35d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c47f-7b90-98e9-6ae0a27cfa83" xlink:href="mirm-20260630.xsd#mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e645a-c47f-750b-aae1-f2f58c6e08ff" xlink:to="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c47f-7b90-98e9-6ae0a27cfa83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e645a-c47f-7ceb-bb43-2d13c60aa956" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e645a-c47f-79a5-9cae-06ade3bf4d43" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e645a-c47f-7ceb-bb43-2d13c60aa956" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e645a-c47f-79a5-9cae-06ade3bf4d43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e645a-c47f-7963-acf9-f6141fcf9e29" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e645a-c47f-7ceb-bb43-2d13c60aa956" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e645a-c47f-7963-acf9-f6141fcf9e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_019e645a-c47f-72b5-a7a6-b5c0d9370e50" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e645a-c47f-7ceb-bb43-2d13c60aa956" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_019e645a-c47f-72b5-a7a6-b5c0d9370e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_019e645a-c47f-70ae-abe2-46a7c696001c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e645a-c47f-7ceb-bb43-2d13c60aa956" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_019e645a-c47f-70ae-abe2-46a7c696001c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019e645a-c47f-752d-a866-6590e51c6060" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e645a-c47f-7ceb-bb43-2d13c60aa956" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019e645a-c47f-752d-a866-6590e51c6060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e645a-c47f-772e-96f7-46dbb0ae73c8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e645a-c47f-7bdf-8433-0b4e28056647" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e645a-c47f-772e-96f7-46dbb0ae73c8" xlink:to="loc_us-gaap_Liabilities_019e645a-c47f-7bdf-8433-0b4e28056647" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e645a-c47f-71d2-a2ef-f8818e407dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e645a-c47f-772e-96f7-46dbb0ae73c8" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e645a-c47f-71d2-a2ef-f8818e407dd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e645a-c47f-73be-9565-feb5048393dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e645a-c47f-772e-96f7-46dbb0ae73c8" xlink:to="loc_us-gaap_StockholdersEquity_019e645a-c47f-73be-9565-feb5048393dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e645a-c47f-7150-894d-1a443ed99e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e645a-c47f-7551-8f12-af4120b0c6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e645a-c47f-7150-894d-1a443ed99e8c" xlink:to="loc_us-gaap_AssetsCurrent_019e645a-c47f-7551-8f12-af4120b0c6d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_019e645a-c47f-7d7b-bc4b-f691ed8a3b60" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e645a-c47f-7150-894d-1a443ed99e8c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_019e645a-c47f-7d7b-bc4b-f691ed8a3b60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e645a-c47f-79fc-bc30-b6a6e686eb38" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e645a-c47f-7150-894d-1a443ed99e8c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019e645a-c47f-79fc-bc30-b6a6e686eb38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_019e645a-c47f-75a3-a4e7-aa2440d81c61" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e645a-c47f-7150-894d-1a443ed99e8c" xlink:to="loc_us-gaap_LongTermInvestments_019e645a-c47f-75a3-a4e7-aa2440d81c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019e645a-c47f-7339-82a8-66f70035f3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e645a-c47f-7150-894d-1a443ed99e8c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019e645a-c47f-7339-82a8-66f70035f3e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e645a-c47f-7a1b-b0d4-d4e028491aab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e645a-c47f-7150-894d-1a443ed99e8c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e645a-c47f-7a1b-b0d4-d4e028491aab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e645a-c47f-79ed-9fad-a7d156c2df25" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e645a-c47f-7150-894d-1a443ed99e8c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e645a-c47f-79ed-9fad-a7d156c2df25" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="mirm-20260630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e645a-c47f-7994-8dd1-1c3f40fef2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_CostOfSales_019e645a-c47f-77b5-83da-937b67b3c3e8" xlink:href="mirm-20260630.xsd#mirm_CostOfSales"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e645a-c47f-7994-8dd1-1c3f40fef2fb" xlink:to="loc_mirm_CostOfSales_019e645a-c47f-77b5-83da-937b67b3c3e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019e645a-c47f-7899-a7b2-19d4aaaada66" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e645a-c47f-7994-8dd1-1c3f40fef2fb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019e645a-c47f-7899-a7b2-19d4aaaada66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_ResearchAndDevelopmentExpenseAcquiredInProcessCost_019e645a-c47f-7096-b0ac-bb48af1cd71e" xlink:href="mirm-20260630.xsd#mirm_ResearchAndDevelopmentExpenseAcquiredInProcessCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e645a-c47f-7994-8dd1-1c3f40fef2fb" xlink:to="loc_mirm_ResearchAndDevelopmentExpenseAcquiredInProcessCost_019e645a-c47f-7096-b0ac-bb48af1cd71e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e645a-c47f-711f-ae18-c2e9ec7b939a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e645a-c47f-7994-8dd1-1c3f40fef2fb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e645a-c47f-711f-ae18-c2e9ec7b939a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e645a-c47f-7c3c-a426-339c1d28ee54" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e645a-c47f-7b81-90b0-62708dd2a5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e645a-c47f-7c3c-a426-339c1d28ee54" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e645a-c47f-7b81-90b0-62708dd2a5d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e645a-c47f-743c-867b-677c15d6245c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e645a-c47f-7c3c-a426-339c1d28ee54" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e645a-c47f-743c-867b-677c15d6245c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019e645a-c47f-7fdf-b198-e46e93d8e8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e645a-c47f-7c3c-a426-339c1d28ee54" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019e645a-c47f-7fdf-b198-e46e93d8e8b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019e645a-c47f-7722-88ac-731c524df05a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e645a-c47f-7c3c-a426-339c1d28ee54" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019e645a-c47f-7722-88ac-731c524df05a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e645a-c47f-79fc-98e9-a8d7fe1cecb3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e645a-c47f-7ad0-b911-743892631851" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c47f-79fc-98e9-a8d7fe1cecb3" xlink:to="loc_us-gaap_OperatingExpenses_019e645a-c47f-7ad0-b911-743892631851" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e645a-c47f-735a-9e86-a5aa0bb4fb24" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c47f-79fc-98e9-a8d7fe1cecb3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e645a-c47f-735a-9e86-a5aa0bb4fb24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e645a-c47f-7f9d-b9c6-35c2b0058f88" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e645a-c47f-7c93-bc7b-7a81c54e63b7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e645a-c47f-7f9d-b9c6-35c2b0058f88" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e645a-c47f-7c93-bc7b-7a81c54e63b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019e645a-c47f-75ae-872d-9d3415e1cc80" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e645a-c47f-7f9d-b9c6-35c2b0058f88" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019e645a-c47f-75ae-872d-9d3415e1cc80" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/CondensedConsolidatedStatementsofComprehensiveLossUnaudited" xlink:type="simple" xlink:href="mirm-20260630.xsd#CondensedConsolidatedStatementsofComprehensiveLossUnaudited"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/CondensedConsolidatedStatementsofComprehensiveLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e645a-c47f-7f5a-b0ad-d4897354f685" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e645a-c47f-7c20-9e37-31fc36cb71b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e645a-c47f-7f5a-b0ad-d4897354f685" xlink:to="loc_us-gaap_NetIncomeLoss_019e645a-c47f-7c20-9e37-31fc36cb71b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_019e645a-c47f-7ec2-9103-dcd757b83767" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e645a-c47f-7f5a-b0ad-d4897354f685" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_019e645a-c47f-7ec2-9103-dcd757b83767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019e645a-c47f-7f41-a4a3-6f9be50ceefa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e645a-c47f-7f5a-b0ad-d4897354f685" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019e645a-c47f-7f41-a4a3-6f9be50ceefa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="mirm-20260630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e645a-c47f-78c1-bf68-5bcc6eda33f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_019e645a-c47f-78eb-aa11-4417c0d335c8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e645a-c47f-78c1-bf68-5bcc6eda33f8" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_019e645a-c47f-78eb-aa11-4417c0d335c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_019e645a-c47f-7839-adc3-4a70e11a610d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e645a-c47f-78c1-bf68-5bcc6eda33f8" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_019e645a-c47f-7839-adc3-4a70e11a610d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_019f89b0-72cc-7654-9bb5-19b8ae6a3022" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e645a-c47f-78c1-bf68-5bcc6eda33f8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_019f89b0-72cc-7654-9bb5-19b8ae6a3022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_019f89b0-72cc-7721-94b8-7697f9c87642" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e645a-c47f-78c1-bf68-5bcc6eda33f8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_019f89b0-72cc-7721-94b8-7697f9c87642" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e645a-c47f-745b-896a-f69eb5431f01" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_019e645a-c47f-7685-88da-aff8912e07cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e645a-c47f-745b-896a-f69eb5431f01" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_019e645a-c47f-7685-88da-aff8912e07cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_019e645a-c47f-7a22-b1ea-283e41452bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e645a-c47f-745b-896a-f69eb5431f01" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_019e645a-c47f-7a22-b1ea-283e41452bf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e645a-c47f-7308-92f0-c0b62f70d0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e645a-c47f-745b-896a-f69eb5431f01" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e645a-c47f-7308-92f0-c0b62f70d0f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019e645a-c47f-78fc-9ebe-7188cc9b1824" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e645a-c47f-745b-896a-f69eb5431f01" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019e645a-c47f-78fc-9ebe-7188cc9b1824" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019e645a-c47f-7099-af6c-30ea069cc300" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_ProfitLoss_019e645a-c47f-7099-af6c-30ea069cc300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e645a-c47f-7a20-9512-fbe900f0723a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_ShareBasedCompensation_019e645a-c47f-7a20-9512-fbe900f0723a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019e645a-c47f-7a56-989f-ef502f9ecad2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019e645a-c47f-7a56-989f-ef502f9ecad2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019e645a-c47f-7bd5-b0db-71861591051e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019e645a-c47f-7bd5-b0db-71861591051e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_019e645a-c47f-7133-b7a1-b9fa3d4acba4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_019e645a-c47f-7133-b7a1-b9fa3d4acba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_NonCashLeaseExpense_019e645a-c47f-7b06-a977-c2ea4293f73e" xlink:href="mirm-20260630.xsd#mirm_NonCashLeaseExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_mirm_NonCashLeaseExpense_019e645a-c47f-7b06-a977-c2ea4293f73e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_InventoryReservesAndFirmPurchaseCommitmentLossesUnderOperatingActivity_019e645a-c47f-7c5b-9597-b5c736ea4d93" xlink:href="mirm-20260630.xsd#mirm_InventoryReservesAndFirmPurchaseCommitmentLossesUnderOperatingActivity"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_mirm_InventoryReservesAndFirmPurchaseCommitmentLossesUnderOperatingActivity_019e645a-c47f-7c5b-9597-b5c736ea4d93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_FairValueOfCommonStockIssuedAsPaymentForAssetAcquisition_019e645a-c47f-7236-92e2-22bdbe527b2a" xlink:href="mirm-20260630.xsd#mirm_FairValueOfCommonStockIssuedAsPaymentForAssetAcquisition"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_mirm_FairValueOfCommonStockIssuedAsPaymentForAssetAcquisition_019e645a-c47f-7236-92e2-22bdbe527b2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_DebtConversionInducementExpense_019e645a-c47f-7a93-a6c6-a8dc5e27c668" xlink:href="mirm-20260630.xsd#mirm_DebtConversionInducementExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_mirm_DebtConversionInducementExpense_019e645a-c47f-7a93-a6c6-a8dc5e27c668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_ChangeInFairValueOfHoldbackLiabilities_019f89ac-576f-73e3-952b-0c44d278252e" xlink:href="mirm-20260630.xsd#mirm_ChangeInFairValueOfHoldbackLiabilities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_mirm_ChangeInFairValueOfHoldbackLiabilities_019f89ac-576f-73e3-952b-0c44d278252e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_019e645a-c47f-763a-b4b7-6a341118ce48" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_019e645a-c47f-763a-b4b7-6a341118ce48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019e645a-c47f-7f7d-9122-73d919956b36" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019e645a-c47f-7f7d-9122-73d919956b36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e645a-c47f-7bf3-8495-c05772f0aecd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e645a-c47f-7bf3-8495-c05772f0aecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_019e645a-c47f-73fc-a075-48886405f179" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_019e645a-c47f-73fc-a075-48886405f179" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019e645a-c47f-7a89-b5ec-68689e147343" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019e645a-c47f-7a89-b5ec-68689e147343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_019e645a-c47f-7bd3-a240-afa92ea5bb76" xlink:href="mirm-20260630.xsd#mirm_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_mirm_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_019e645a-c47f-7bd3-a240-afa92ea5bb76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_IncreaseDecreaseInHoldbackLiabilities_019e645a-c47f-78dc-9c5e-7938eb3ae062" xlink:href="mirm-20260630.xsd#mirm_IncreaseDecreaseInHoldbackLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_mirm_IncreaseDecreaseInHoldbackLiabilities_019e645a-c47f-78dc-9c5e-7938eb3ae062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019e645a-c47f-741c-8f88-6039fbf7bbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-7c4f-b106-4ccfdbe95543" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019e645a-c47f-741c-8f88-6039fbf7bbd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e645a-c47f-732a-bddc-28ff6b717425" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e645a-c47f-79d3-b181-add3832506b9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e645a-c47f-732a-bddc-28ff6b717425" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e645a-c47f-79d3-b181-add3832506b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e645a-c47f-72c0-81c1-608ffa3eaaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e645a-c47f-732a-bddc-28ff6b717425" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e645a-c47f-72c0-81c1-608ffa3eaaaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-76f9-af82-cc163a63fa59" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e645a-c47f-732a-bddc-28ff6b717425" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e645a-c47f-76f9-af82-cc163a63fa59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e645a-c47f-7c15-a3a6-8991764dd3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e645a-c47f-732a-bddc-28ff6b717425" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e645a-c47f-7c15-a3a6-8991764dd3fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashReportedWithintheConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashReportedWithintheConsolidatedBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashReportedWithintheConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e645a-c47f-71dc-8fe1-21c65e3ece82" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e645a-c47f-7c80-bc44-82cc7c79adf1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e645a-c47f-71dc-8fe1-21c65e3ece82" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e645a-c47f-7c80-bc44-82cc7c79adf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalents_019e645a-c47f-7d25-addb-035202f1c1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e645a-c47f-71dc-8fe1-21c65e3ece82" xlink:to="loc_us-gaap_RestrictedCashEquivalents_019e645a-c47f-7d25-addb-035202f1c1a8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#SummaryofSignificantAccountingPoliciesScheduleofComputationofBasicandDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e645a-c47f-70af-b0ba-3b693f3742c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_WeightedAverageNumberOfSharesOutstandingExcludingWarrantOptionsBasic_019e645a-c47f-73c8-a23d-7dd725efbaa7" xlink:href="mirm-20260630.xsd#mirm_WeightedAverageNumberOfSharesOutstandingExcludingWarrantOptionsBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e645a-c47f-70af-b0ba-3b693f3742c2" xlink:to="loc_mirm_WeightedAverageNumberOfSharesOutstandingExcludingWarrantOptionsBasic_019e645a-c47f-73c8-a23d-7dd725efbaa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_019e645a-c47f-766c-8342-9fbb0cb7a0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e645a-c47f-70af-b0ba-3b693f3742c2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_019e645a-c47f-766c-8342-9fbb0cb7a0cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019eba34-de8f-7d6e-ac15-36a34f0fbc27" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_WeightedAverageNumberOfSharesOutstandingExcludingWarrantOptionsBasic_019eba35-529e-7a4f-a339-a47e33c9dca4" xlink:href="mirm-20260630.xsd#mirm_WeightedAverageNumberOfSharesOutstandingExcludingWarrantOptionsBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019eba34-de8f-7d6e-ac15-36a34f0fbc27" xlink:to="loc_mirm_WeightedAverageNumberOfSharesOutstandingExcludingWarrantOptionsBasic_019eba35-529e-7a4f-a339-a47e33c9dca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_019eba35-86fa-7099-b3e6-f6c9274c2fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019eba34-de8f-7d6e-ac15-36a34f0fbc27" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_019eba35-86fa-7099-b3e6-f6c9274c2fa2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiestoFairValueMeasurementsonRecurringBasisandLevelofInputMeasurementsDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiestoFairValueMeasurementsonRecurringBasisandLevelofInputMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiestoFairValueMeasurementsonRecurringBasisandLevelofInputMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_019fb393-bf37-7ea7-b287-db8dbd361433" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_IndemnificationLiabilityFairValueDisclosure_019fb393-bf37-7caf-a3fd-170ae40f62e9" xlink:href="mirm-20260630.xsd#mirm_IndemnificationLiabilityFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_019fb393-bf37-7ea7-b287-db8dbd361433" xlink:to="loc_mirm_IndemnificationLiabilityFairValueDisclosure_019fb393-bf37-7caf-a3fd-170ae40f62e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019fb392-3dab-7fc7-bdd1-9edd05093938" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019fb392-3dab-7ac7-90a4-c06ec3fd9317" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019fb392-3dab-7fc7-bdd1-9edd05093938" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019fb392-3dab-7ac7-90a4-c06ec3fd9317" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/FinancialInstrumentsScheduleofFairValueandAmortizedCostofCashEquivalentsandAvailableforsaleInvestmentsbyMajorSecurityTypeDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#FinancialInstrumentsScheduleofFairValueandAmortizedCostofCashEquivalentsandAvailableforsaleInvestmentsbyMajorSecurityTypeDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/FinancialInstrumentsScheduleofFairValueandAmortizedCostofCashEquivalentsandAvailableforsaleInvestmentsbyMajorSecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mirm_CashEquivalentsAndAvailableForSaleSecuritiesDebtSecurities_019e645a-c47f-7373-b0da-2c6a38f0dfaf" xlink:href="mirm-20260630.xsd#mirm_CashEquivalentsAndAvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e645a-c47f-73d3-9750-fc76a57ae7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_CashEquivalentsAndAvailableForSaleSecuritiesDebtSecurities_019e645a-c47f-7373-b0da-2c6a38f0dfaf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e645a-c47f-73d3-9750-fc76a57ae7eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e645a-c47f-79b6-b81b-b955f7effb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_CashEquivalentsAndAvailableForSaleSecuritiesDebtSecurities_019e645a-c47f-7373-b0da-2c6a38f0dfaf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e645a-c47f-79b6-b81b-b955f7effb6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_019e645a-c47f-7580-b82f-8afd12176f32" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_CashEquivalentsAndAvailableForSaleSecuritiesDebtSecurities_019e645a-c47f-7373-b0da-2c6a38f0dfaf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_019e645a-c47f-7580-b82f-8afd12176f32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e645a-c47f-779e-9758-9dcc08864c81" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e645a-c47f-701b-bd67-9bfb6d998a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e645a-c47f-779e-9758-9dcc08864c81" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e645a-c47f-701b-bd67-9bfb6d998a1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e645a-c47f-7bde-84cb-1d09eef82be8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e645a-c47f-779e-9758-9dcc08864c81" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e645a-c47f-7bde-84cb-1d09eef82be8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e645a-c47f-7c2c-89ef-74cc5e1c0e74" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e645a-c47f-779e-9758-9dcc08864c81" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e645a-c47f-7c2c-89ef-74cc5e1c0e74" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/FinancialInstrumentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#FinancialInstrumentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/FinancialInstrumentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_019e645a-c47f-7e97-8f22-f01170f544c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_019e645a-c47f-72f1-ab45-036b21d0d27f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_019e645a-c47f-7e97-8f22-f01170f544c2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_019e645a-c47f-72f1-ab45-036b21d0d27f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearOneAndTwo_019e645a-c47f-73cd-b5f5-dd0b78ddab34" xlink:href="mirm-20260630.xsd#mirm_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearOneAndTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_019e645a-c47f-7e97-8f22-f01170f544c2" xlink:to="loc_mirm_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearOneAndTwo_019e645a-c47f-73cd-b5f5-dd0b78ddab34" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofInventoryDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#BalanceSheetComponentsScheduleofInventoryDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019e645a-c480-79fd-a338-c248a2e0058a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_019e645a-c480-7d74-acc5-ac60b9073b50" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019e645a-c480-79fd-a338-c248a2e0058a" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_019e645a-c480-7d74-acc5-ac60b9073b50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_019e645a-c480-7551-aacd-8207278b2f24" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019e645a-c480-79fd-a338-c248a2e0058a" xlink:to="loc_us-gaap_InventoryWorkInProcess_019e645a-c480-7551-aacd-8207278b2f24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_019e645a-c480-7b2d-9f01-9732c575115a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019e645a-c480-79fd-a338-c248a2e0058a" xlink:to="loc_us-gaap_InventoryFinishedGoods_019e645a-c480-7b2d-9f01-9732c575115a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#BalanceSheetComponentsScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-760c-9e8e-027139b3b923" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019e645a-c480-770c-8ced-aa46f86890ba" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-760c-9e8e-027139b3b923" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019e645a-c480-770c-8ced-aa46f86890ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019e645a-c480-7c2e-b14b-02bbdf7bf3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-760c-9e8e-027139b3b923" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019e645a-c480-7c2e-b14b-02bbdf7bf3ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofEstimatedFutureAmortizationExpenseAssociatedwithIntangibleAssetsDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#BalanceSheetComponentsScheduleofEstimatedFutureAmortizationExpenseAssociatedwithIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofEstimatedFutureAmortizationExpenseAssociatedwithIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-7775-8c83-f4dca0492044" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_019e645a-c480-7713-b874-bb6593512325" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-7775-8c83-f4dca0492044" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_019e645a-c480-7713-b874-bb6593512325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_019e645a-c480-7e4e-880f-5c1f6ad0fb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-7775-8c83-f4dca0492044" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_019e645a-c480-7e4e-880f-5c1f6ad0fb1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_019e645a-c480-7657-8eeb-e095501eaf96" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-7775-8c83-f4dca0492044" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_019e645a-c480-7657-8eeb-e095501eaf96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_019e645a-c480-79e7-aac0-9c0ceafcffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-7775-8c83-f4dca0492044" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_019e645a-c480-79e7-aac0-9c0ceafcffd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_019e645a-c480-761c-aa8e-a1ce3b08642d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-7775-8c83-f4dca0492044" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_019e645a-c480-761c-aa8e-a1ce3b08642d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_019e645a-c480-7e31-b058-6cb258ac314a" xlink:href="mirm-20260630.xsd#mirm_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e645a-c480-7775-8c83-f4dca0492044" xlink:to="loc_mirm_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_019e645a-c480-7e31-b058-6cb258ac314a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#BalanceSheetComponentsScheduleofAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:href="mirm-20260630.xsd#mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AccruedSalesDeductionsAndOtherCurrent_019e645a-c480-779c-9726-bbfea62bdbfe" xlink:href="mirm-20260630.xsd#mirm_AccruedSalesDeductionsAndOtherCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_mirm_AccruedSalesDeductionsAndOtherCurrent_019e645a-c480-779c-9726-bbfea62bdbfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e645a-c480-77c0-8a50-8877c0caa947" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e645a-c480-77c0-8a50-8877c0caa947" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_019e645a-c480-764c-8829-80d117c74e61" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_019e645a-c480-764c-8829-80d117c74e61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019e645a-c480-7a40-97c1-ca0d05189481" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019e645a-c480-7a40-97c1-ca0d05189481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AccruedClinicalTrialsCurrent_019e645a-c480-79a6-b950-a20bfb31ded3" xlink:href="mirm-20260630.xsd#mirm_AccruedClinicalTrialsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_mirm_AccruedClinicalTrialsCurrent_019e645a-c480-79a6-b950-a20bfb31ded3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AccruedContractManufacturingAndNonClinicalCostsCurrent_019e645a-c480-795f-b5be-b0ec909b7799" xlink:href="mirm-20260630.xsd#mirm_AccruedContractManufacturingAndNonClinicalCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_mirm_AccruedContractManufacturingAndNonClinicalCostsCurrent_019e645a-c480-795f-b5be-b0ec909b7799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_019e645a-c480-727a-8bc2-d5ea5009252c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_us-gaap_InterestPayableCurrent_019e645a-c480-727a-8bc2-d5ea5009252c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AccruedLossOnFirmPurchaseCommitmentsCurrent_019e645a-c480-72c9-ad19-a410c9f2a744" xlink:href="mirm-20260630.xsd#mirm_AccruedLossOnFirmPurchaseCommitmentsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_mirm_AccruedLossOnFirmPurchaseCommitmentsCurrent_019e645a-c480-72c9-ad19-a410c9f2a744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e645a-c480-7da7-a1d0-6d16b37de6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e645a-c480-7da7-a1d0-6d16b37de6ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AccruedMilestonePaymentCurrent_019e645a-c480-7e79-9bc9-cbcda8203d84" xlink:href="mirm-20260630.xsd#mirm_AccruedMilestonePaymentCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e645a-c480-79e3-9072-e47d0c99a0b0" xlink:to="loc_mirm_AccruedMilestonePaymentCurrent_019e645a-c480-7e79-9bc9-cbcda8203d84" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofNoncurrentLiabilitiesDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#BalanceSheetComponentsScheduleofNoncurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/BalanceSheetComponentsScheduleofNoncurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019e645a-c480-7385-a4f6-6fdb040d96c7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AccruedSalesDeductionAndOtherNoncurrentLiabilities_019e645a-c480-7f72-b79d-35f6c6680ae2" xlink:href="mirm-20260630.xsd#mirm_AccruedSalesDeductionAndOtherNoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_019e645a-c480-7385-a4f6-6fdb040d96c7" xlink:to="loc_mirm_AccruedSalesDeductionAndOtherNoncurrentLiabilities_019e645a-c480-7f72-b79d-35f6c6680ae2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AccruedLossOnFirmPurchaseCommitmentsNoncurrent_019e645a-c480-7405-9c66-eacf286981a4" xlink:href="mirm-20260630.xsd#mirm_AccruedLossOnFirmPurchaseCommitmentsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_019e645a-c480-7385-a4f6-6fdb040d96c7" xlink:to="loc_mirm_AccruedLossOnFirmPurchaseCommitmentsNoncurrent_019e645a-c480-7405-9c66-eacf286981a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_019e645a-c480-79ca-b7b9-03013874a68a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_019e645a-c480-7385-a4f6-6fdb040d96c7" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_019e645a-c480-79ca-b7b9-03013874a68a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/AssetAcquisitionsScheduleofConsiderationPaidandAllocationofPurchasePriceforAcquisitionDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#AssetAcquisitionsScheduleofConsiderationPaidandAllocationofPurchasePriceforAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/AssetAcquisitionsScheduleofConsiderationPaidandAllocationofPurchasePriceforAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionAssetsAcquired_019e645a-c480-735d-a9cd-b2361b052436" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionInProcessResearchAndDevelopment_019e645a-c480-7004-9880-1f92efb1d2e2" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionInProcessResearchAndDevelopment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionAssetsAcquired_019e645a-c480-735d-a9cd-b2361b052436" xlink:to="loc_mirm_AssetAcquisitionInProcessResearchAndDevelopment_019e645a-c480-7004-9880-1f92efb1d2e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionAssembledWorkforce_019e645a-c480-74de-a036-aae1fea15b48" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionAssembledWorkforce"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionAssetsAcquired_019e645a-c480-735d-a9cd-b2361b052436" xlink:to="loc_mirm_AssetAcquisitionAssembledWorkforce_019e645a-c480-74de-a036-aae1fea15b48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionCashAndCashEquivalents_019e645a-c480-76fb-9112-cb786ad4275d" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionAssetsAcquired_019e645a-c480-735d-a9cd-b2361b052436" xlink:to="loc_mirm_AssetAcquisitionCashAndCashEquivalents_019e645a-c480-76fb-9112-cb786ad4275d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionPrepaidExpensesAndOtherCurrentAssets_019e645a-c480-775a-b0e3-ba5f23ae916d" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionPrepaidExpensesAndOtherCurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionAssetsAcquired_019e645a-c480-735d-a9cd-b2361b052436" xlink:to="loc_mirm_AssetAcquisitionPrepaidExpensesAndOtherCurrentAssets_019e645a-c480-775a-b0e3-ba5f23ae916d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionOperatingLeaseRightOfUseAssets_019e645a-c480-79f1-a13e-f56c3d916327" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionAssetsAcquired_019e645a-c480-735d-a9cd-b2361b052436" xlink:to="loc_mirm_AssetAcquisitionOperatingLeaseRightOfUseAssets_019e645a-c480-79f1-a13e-f56c3d916327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionOtherNonCurrentAssets_019e645a-c480-7ebc-9630-72e8d49a5e50" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionOtherNonCurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionAssetsAcquired_019e645a-c480-735d-a9cd-b2361b052436" xlink:to="loc_mirm_AssetAcquisitionOtherNonCurrentAssets_019e645a-c480-7ebc-9630-72e8d49a5e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_019e645a-c480-7b5d-b47b-c7ad01748a84" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionAssetsAcquired_019e645a-c480-73d6-bba3-df1695fbc73a" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_019e645a-c480-7b5d-b47b-c7ad01748a84" xlink:to="loc_mirm_AssetAcquisitionAssetsAcquired_019e645a-c480-73d6-bba3-df1695fbc73a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionLiabilitiesAssumed_019e645a-c480-78df-8ebb-af79bddc9fd2" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionLiabilitiesAssumed"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_019e645a-c480-7b5d-b47b-c7ad01748a84" xlink:to="loc_mirm_AssetAcquisitionLiabilitiesAssumed_019e645a-c480-78df-8ebb-af79bddc9fd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionLiabilitiesAssumed_019e645a-c480-7614-9dfd-3beeff69ddd9" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionLiabilitiesAssumed"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionAccountsPayable_019e645a-c480-728e-b21d-49633d0e7883" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionLiabilitiesAssumed_019e645a-c480-7614-9dfd-3beeff69ddd9" xlink:to="loc_mirm_AssetAcquisitionAccountsPayable_019e645a-c480-728e-b21d-49633d0e7883" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionAccruedExpensesAndOtherCurrentLiabilities_019e645a-c480-72cb-b181-2079c3e16177" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionLiabilitiesAssumed_019e645a-c480-7614-9dfd-3beeff69ddd9" xlink:to="loc_mirm_AssetAcquisitionAccruedExpensesAndOtherCurrentLiabilities_019e645a-c480-72cb-b181-2079c3e16177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionOperatingLeaseLiabilitiesNoncurrent_019e645a-c480-7877-ac0e-04f8ae1ff9c6" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionOperatingLeaseLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_mirm_AssetAcquisitionLiabilitiesAssumed_019e645a-c480-7614-9dfd-3beeff69ddd9" xlink:to="loc_mirm_AssetAcquisitionOperatingLeaseLiabilitiesNoncurrent_019e645a-c480-7877-ac0e-04f8ae1ff9c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019e645a-c480-7e76-af7b-6f97e4ef0494" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_019e645a-c480-73c0-ad18-3a2307f97885" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019e645a-c480-7e76-af7b-6f97e4ef0494" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_019e645a-c480-73c0-ad18-3a2307f97885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionConsiderationTransferredCashConsideration_019e645a-c480-7734-ab26-18fda4eeecbb" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionConsiderationTransferredCashConsideration"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019e645a-c480-7e76-af7b-6f97e4ef0494" xlink:to="loc_mirm_AssetAcquisitionConsiderationTransferredCashConsideration_019e645a-c480-7734-ab26-18fda4eeecbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionConsiderationTransferredCashIndemnificationHoldback_019e645a-c480-79a3-a1bf-6f4f4bd0eedc" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionConsiderationTransferredCashIndemnificationHoldback"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019e645a-c480-7e76-af7b-6f97e4ef0494" xlink:to="loc_mirm_AssetAcquisitionConsiderationTransferredCashIndemnificationHoldback_019e645a-c480-79a3-a1bf-6f4f4bd0eedc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionConsiderationTransferredDeferredConsideration_019e645a-c480-726d-89cb-b139ad350072" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionConsiderationTransferredDeferredConsideration"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019e645a-c480-7e76-af7b-6f97e4ef0494" xlink:to="loc_mirm_AssetAcquisitionConsiderationTransferredDeferredConsideration_019e645a-c480-726d-89cb-b139ad350072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_019e645a-c480-77da-882c-6da0668a443d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019e645a-c480-7e76-af7b-6f97e4ef0494" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_019e645a-c480-77da-882c-6da0668a443d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionConsiderationTransferredCashIndemnificationHoldbackAndWorkingCapital_019e645a-c480-7df3-ba2a-6cd4269f7b76" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionConsiderationTransferredCashIndemnificationHoldbackAndWorkingCapital"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019e645a-c480-7e76-af7b-6f97e4ef0494" xlink:to="loc_mirm_AssetAcquisitionConsiderationTransferredCashIndemnificationHoldbackAndWorkingCapital_019e645a-c480-7df3-ba2a-6cd4269f7b76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_AssetAcquisitionConsiderationTransferredEquityIndemnificationHoldback_019e645a-c480-7693-923d-25eeb0addf70" xlink:href="mirm-20260630.xsd#mirm_AssetAcquisitionConsiderationTransferredEquityIndemnificationHoldback"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019e645a-c480-7e76-af7b-6f97e4ef0494" xlink:to="loc_mirm_AssetAcquisitionConsiderationTransferredEquityIndemnificationHoldback_019e645a-c480-7693-923d-25eeb0addf70" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/LeasesScheduleofUndiscountedFutureMinimumPaymentsunderOperatingLeasesDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#LeasesScheduleofUndiscountedFutureMinimumPaymentsunderOperatingLeasesDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/LeasesScheduleofUndiscountedFutureMinimumPaymentsunderOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-77e3-a87d-920744856a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019e645a-c480-787d-b03f-5810f675a815" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-77e3-a87d-920744856a1e" xlink:to="loc_us-gaap_OperatingLeaseLiability_019e645a-c480-787d-b03f-5810f675a815" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019e645a-c480-7257-83d1-eb03d2b89bda" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-77e3-a87d-920744856a1e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019e645a-c480-7257-83d1-eb03d2b89bda" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/LeasesScheduleofUndiscountedFutureMinimumPaymentsunderOperatingLeasesDetails_1" xlink:type="simple" xlink:href="mirm-20260630.xsd#LeasesScheduleofUndiscountedFutureMinimumPaymentsunderOperatingLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/LeasesScheduleofUndiscountedFutureMinimumPaymentsunderOperatingLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-7d0e-93c9-5c3d668a423a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019e645a-c480-7a98-aaa2-d6cca0f393a3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-7d0e-93c9-5c3d668a423a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019e645a-c480-7a98-aaa2-d6cca0f393a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019e645a-c480-730c-9c7e-c3d46eb8ce73" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-7d0e-93c9-5c3d668a423a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019e645a-c480-730c-9c7e-c3d46eb8ce73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019e645a-c480-73ec-9e27-af10f8eedef5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-7d0e-93c9-5c3d668a423a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019e645a-c480-73ec-9e27-af10f8eedef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019e645a-c480-7120-a929-cf34064da766" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-7d0e-93c9-5c3d668a423a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019e645a-c480-7120-a929-cf34064da766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019e645a-c480-7f2c-8716-69e8b50268da" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-7d0e-93c9-5c3d668a423a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019e645a-c480-7f2c-8716-69e8b50268da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_019e645a-c480-7e31-80c5-32f1f2b80345" xlink:href="mirm-20260630.xsd#mirm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e645a-c480-7d0e-93c9-5c3d668a423a" xlink:to="loc_mirm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_019e645a-c480-7e31-80c5-32f1f2b80345" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#ConvertibleNotesScheduleOfConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/ConvertibleNotesScheduleOfConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_019e645a-c480-7ff7-8db8-37daa8c45db2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019e645a-c480-75d8-b579-4d47d9b13084" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_019e645a-c480-7ff7-8db8-37daa8c45db2" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019e645a-c480-75d8-b579-4d47d9b13084" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019e645a-c480-7a16-9577-214a1f723808" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_019e645a-c480-7ff7-8db8-37daa8c45db2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019e645a-c480-7a16-9577-214a1f723808" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/ConvertibleNotesScheduleofInterestExpenseRelatedtoConvertibleNotesDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#ConvertibleNotesScheduleofInterestExpenseRelatedtoConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/ConvertibleNotesScheduleofInterestExpenseRelatedtoConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_019e645a-c480-7443-9642-e9b621506338" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019e645a-c480-7896-90b3-03cb153ed7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_019e645a-c480-7443-9642-e9b621506338" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019e645a-c480-7896-90b3-03cb153ed7ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_019e645a-c480-7e8b-bcc8-5667fb79587c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_019e645a-c480-7443-9642-e9b621506338" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_019e645a-c480-7e8b-bcc8-5667fb79587c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mirumpharma.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="mirm-20260630.xsd#SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:calculationLink xlink:role="http://mirumpharma.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e645a-c52d-75f8-af8b-2b2b652644ce" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_CommercializationAndMedicalAffairsExpensesExcludingStockBasedCompensation_019e645a-c52d-7322-98b2-2a74a4c2109b" xlink:href="mirm-20260630.xsd#mirm_CommercializationAndMedicalAffairsExpensesExcludingStockBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c52d-75f8-af8b-2b2b652644ce" xlink:to="loc_mirm_CommercializationAndMedicalAffairsExpensesExcludingStockBasedCompensation_019e645a-c52d-7322-98b2-2a74a4c2109b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_ResearchAndDevelopmentExpensesExcludingStockBasedCompensation_019e645a-c52d-749c-b960-8fceecbc33cd" xlink:href="mirm-20260630.xsd#mirm_ResearchAndDevelopmentExpensesExcludingStockBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c52d-75f8-af8b-2b2b652644ce" xlink:to="loc_mirm_ResearchAndDevelopmentExpensesExcludingStockBasedCompensation_019e645a-c52d-749c-b960-8fceecbc33cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_019e645a-c52d-7747-ab8c-2b84a83dbe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c52d-75f8-af8b-2b2b652644ce" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_019e645a-c52d-7747-ab8c-2b84a83dbe0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e645a-c52d-77e5-8830-c2b452276881" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c52d-75f8-af8b-2b2b652644ce" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e645a-c52d-77e5-8830-c2b452276881" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e645a-c52d-7ccc-b984-dbdf53e24b69" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c52d-75f8-af8b-2b2b652644ce" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019e645a-c52d-7ccc-b984-dbdf53e24b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e645a-c52d-7279-9f17-1c53379f2c91" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c52d-75f8-af8b-2b2b652644ce" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e645a-c52d-7279-9f17-1c53379f2c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_019e645a-c52d-7bd8-b8f4-827d58d7f0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c52d-75f8-af8b-2b2b652644ce" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_019e645a-c52d-7bd8-b8f4-827d58d7f0e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mirm_ResearchAndDevelopmentExpenseAcquiredInProcessCost_019e645a-c52d-789c-be50-29399ba86ee2" xlink:href="mirm-20260630.xsd#mirm_ResearchAndDevelopmentExpenseAcquiredInProcessCost"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e645a-c52d-75f8-af8b-2b2b652644ce" xlink:to="loc_mirm_ResearchAndDevelopmentExpenseAcquiredInProcessCost_019e645a-c52d-789c-be50-29399ba86ee2" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
